Large and unequal life expectancy declines in India during COVID-19
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Jun-2024 12:09 ET (14-Jun-2024 16:09 GMT/UTC)
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus. The study, published in the journal Nature Communications, tested an OHSU-developed vaccine platform against the virus considered most likely to trigger the next pandemic.
China’s economy, long an engine of world growth, has been sputtering lately. During the second quarter of 2024, it grew at an annual rate of 4.7% — down from an average 7% a year during the past decade. For the next two years, the International Monetary Fund forecasts more of the same.
Analysts have blamed China’s slowdown on short-term factors, such as debt-ridden real estate and a delayed recovery from the COVID-19 pandemic. But new research from Texas McCombs suggests a longer-term problem: an erosion of private property rights.
The study by Kishore Gawande, chair of the Department of Business, Government & Society, looks at what happened after China granted nationwide protection to private property rights in 2007. It finds that the law turbocharged China’s business climate.
In an editorial for the scientific journal Eurosurveillance, the incoming ECDC Director Dr Pamela Rendi Wagner outlined her vision for the European Union’s public health agency, highlighting the mounting challenges to public health after the COVID-19 pandemic, including war in Europe, climate change, and increasing social inequalities. She also emphasised the importance of reinforcing and restoring public trust in science.
Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed that testing for viral drug resistance could improve treatment in cases where treatment has failed. However, a research team led by the University of Basel, Switzerland, now shows that it is much more important to support patients in taking their medication regularly.